Association between metabolic surgery and cardiovascular outcome in patients with hypertension: A nationwide matched cohort study

Autoři: Erik Stenberg aff001;  Yang Cao aff002;  Richard Marsk aff003;  Magnus Sundbom aff004;  Tomas Jernberg aff005;  Erik Näslund aff003
Působiště autorů: Department of Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden aff001;  Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden aff002;  Division of Surgery, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden aff003;  Department of Surgical Sciences, Uppsala University, Uppsala, Sweden aff004;  Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden aff005
Vyšlo v časopise: Association between metabolic surgery and cardiovascular outcome in patients with hypertension: A nationwide matched cohort study. PLoS Med 17(9): e32767. doi:10.1371/journal.pmed.1003307
Kategorie: Research Article
doi: 10.1371/journal.pmed.1003307



Hypertension, together with obesity, is a leading cause of mortality and disability. Whilst metabolic surgery offers remission of several metabolic comorbidities, the effect for patients with hypertension remains controversial. The objective of the present study was to evaluate the effect of metabolic surgery on cardiovascular events and mortality on patients with morbid obesity (body mass index [BMI] ≥ 35 kg/m2) and hypertension.

Methods and findings

We conducted a matched cohort study of 11,863 patients with morbid obesity and pharmacologically treated hypertension operated on with metabolic surgery and a matched non-operated–on control group of 26,199 subjects with hypertension (matched by age, sex, and area of residence) of varied matching ratios from 1:1 to 1:9, using data from the Scandinavian Obesity Surgery Register (SOReg), the Swedish National Patient Registers (NPR) for in-hospital and outpatient care, the Swedish Prescribed Drug Register, and Statistics Sweden. The main outcome was major adverse cardiovascular event (MACE), defined as first occurrence of acute coronary syndrome (ACS) event, cerebrovascular event, fatal cardiovascular event, or unattended sudden cardiac death. The mean age in the study group was 52.1 ± 7.46 years, with 65.8% being women (n = 7,810), and mean BMI was 41.9 ± 5.43 kg/m2. MACEs occurred in 379 operated-on patients (3.2%) and 1,125 subjects in the control group (4.5%). After adjustment for duration of hypertension, comorbidities, and education, a reduction in risk was seen in the metabolic surgery group (adjusted hazard ratio [HR] 0.73, 95% confidence intervals [CIs] 0.64–0.84, P < 0.001). The surgery group had lower risk for ACS events (adjusted HR 0.52, 95% CI 0.41–0.66, P < 0.001) and a tendency towards lower risk for cerebrovascular events (adjusted HR 0.81, 95% CI 0.63–1.01, P = 0.060) compared with controls. The main limitations with the study were the lack of information on BMI and history of smoking in the control group and the nonrandomised study design.


Metabolic surgery on patients with morbid obesity and pharmacologically treated hypertension was associated with lower risk for MACEs and all-cause mortality compared with age- and sex-matched controls with hypertension from the general population.

Klíčová slova:

Cardiovascular disease risk – Digestive system procedures – Epidemiology – Hypertension – Morbid obesity – Surgical and invasive medical procedures – Type 2 diabetes – Type 2 diabetes risk


1. Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A, et al. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med. 2017;377(1):13–27. doi: 10.1056/NEJMoa1614362 28604169

2. Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, Danaei G. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet. 2014;383(9921):970–83. doi: 10.1016/S0140-6736(13)61836-X 24269108

3. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1923–94. doi: 10.1016/S0140-6736(18)32225-6 30496105

4. NCD Risk Factor Collaboration. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet. 2016;387(10026):1377–96. doi: 10.1016/S0140-6736(16)30054-X 27115820

5. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011;377(9765):557–67. doi: 10.1016/S0140-6736(10)62037-5 21295846

6. Sjostrom L. Review of the key results from the Swedish Obese Subjects (SOS) trial—a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273(3):219–34. doi: 10.1111/joim.12012 23163728

7. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, et al. Bariatric Surgery versus Intensive Medical Therapy for Diabetes—5-Year Outcomes. N Engl J Med. 2017;376(7):641–51. doi: 10.1056/NEJMoa1600869 28199805

8. Backman O, Bruze G, Naslund I, Ottosson J, Marsk R, Neovius M, et al. Gastric Bypass Surgery Reduces De Novo Cases of Type 2 Diabetes to Population Levels: A Nationwide Cohort Study From Sweden. Ann Surg. 2019;269(5):895–902. doi: 10.1097/SLA.0000000000002983 30102631

9. Cohen JB. Hypertension in Obesity and the Impact of Weight Loss. Curr Cardiol Rep. 2017;19(10):98. doi: 10.1007/s11886-017-0912-4 28840500

10. Courcoulas AP, King WC, Belle SH, Berk P, Flum DR, Garcia L, et al. Seven-Year Weight Trajectories and Health Outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) Study. JAMA Surg. 2018;153(5):427–34. doi: 10.1001/jamasurg.2017.5025 29214306

11. Schiavon CA, Bersch-Ferreira AC, Santucci EV, Oliveira JD, Torreglosa CR, Bueno PT, et al. Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension). Circulation. 2018;137(11):1132–42. doi: 10.1161/CIRCULATIONAHA.117.032130 29133606

12. Hedenbro JL, Naslund E, Boman L, Lundegardh G, Bylund A, Ekelund M, et al. Formation of the Scandinavian Obesity Surgery Registry, SOReg. Obes Surg. 2015;25(10):1893–900. doi: 10.1007/s11695-015-1619-5 25703826

13. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450. doi: 10.1186/1471-2458-11-450 21658213

14. Brooke HL, Talback M, Hornblad J, Johansson LA, Ludvigsson JF, Druid H, et al. The Swedish cause of death register. Eur J Epidemiol. 2017;32(9):765–73. doi: 10.1007/s10654-017-0316-1 28983736

15. Wallerstedt SM, Wettermark B, Hoffmann M. The First Decade with the Swedish Prescribed Drug Register—A Systematic Review of the Output in the Scientific Literature. Basic Clin Pharmacol Toxicol. 2016;119(5):464–9. doi: 10.1111/bcpt.12613 27112967

16. Riley CM, Sciurba FC. Diagnosis and Outpatient Management of Chronic Obstructive Pulmonary Disease: A Review. JAMA. 2019;321(8):786–97. doi: 10.1001/jama.2019.0131 30806700

17. Olbers T, Lonroth H, Fagevik-Olsen M, Lundell L. Laparoscopic gastric bypass: development of technique, respiratory function, and long-term outcome. Obes Surg. 2003;13(3):364–70. doi: 10.1381/096089203765887679 12841895

18. Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52. doi: 10.1056/NEJMoa066254 17715408

19. Sjostrom L, Peltonen M, Jacobson P, Sjostrom CD, Karason K, Wedel H, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65. doi: 10.1001/jama.2011.1914 22215166

20. Aminian A, Zajichek A, Arterburn DE, Wolski KE, Brethauer SA, Schauer PR, et al. Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity. JAMA. 2019;322(13):1271–82. doi: 10.1001/jama.2019.14231 31475297

21. Moussa O, Ardissino M, Heaton T, Tang A, Khan O, Ziprin P, et al. Effect of bariatric surgery on long-term cardiovascular outcomes: a nationwide nested cohort study. Eur Heart J. 2020;41(28):2660–2667. doi: 10.1093/eurheartj/ehaa069 32188981

22. Fisher DP, Johnson E, Haneuse S, Arterburn D, Coleman KJ, O'Connor PJ, et al. Association Between Bariatric Surgery and Macrovascular Disease Outcomes in Patients With Type 2 Diabetes and Severe Obesity. JAMA. 2018;320(15):1570–82. doi: 10.1001/jama.2018.14619 30326126

23. Han H, Chen L, Wang M, Wei X, Ruan Y, He J. Benefits of bariatric surgery in patients with acute ischemic stroke-a national population-based study. Surg Obes Relat Dis. 2019;15(11):1934–42. doi: 10.1016/j.soard.2019.08.020 31575465

24. Tillmann T, Vaucher J, Okbay A, Pikhart H, Peasey A, Kubinova R, et al. Education and coronary heart disease: mendelian randomisation study. BMJ. 2017;358:j3542. doi: 10.1136/bmj.j3542 28855160

25. Jakobsen GS, Smastuen MC, Sandbu R, Nordstrand N, Hofso D, Lindberg M, et al. Association of Bariatric Surgery vs Medical Obesity Treatment With Long-term Medical Complications and Obesity-Related Comorbidities. JAMA. 2018;319(3):291–301. doi: 10.1001/jama.2017.21055 29340680

26. Lager CJ, Esfandiari NH, Luo Y, Subauste AR, Kraftson AT, Brown MB, et al. Metabolic Parameters, Weight Loss, and Comorbidities 4 Years After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy. Obes Surg. 2018;28(11):3415–23. doi: 10.1007/s11695-018-3346-1 29909517

27. Livingston EH. Reimagining Obesity in 2018: A JAMA Theme Issue on Obesity. JAMA. 2018;319(3):238–40. doi: 10.1001/jama.2017.21779 29340660

28. Benaiges D, Sague M, Flores-Le Roux JA, Pedro-Botet J, Ramon JM, Villatoro M, et al. Predictors of Hypertension Remission and Recurrence After Bariatric Surgery. Am J Hypertens. 2016;29(5):653–9. doi: 10.1093/ajh/hpv153 26350297

29. Leeman M, van Mil SR, Al-Ghanam I, Biter LU, Dunkelgrun M, Castro Cabezas M. Structural and functional vascular improvement 1 year after bariatric surgery: a prospective cohort study. Surg Obes Relat Dis. 2019;15(10):1773–79. doi: 10.1016/j.soard.2019.08.012 31558408

30. Tschoner A, Sturm W, Gelsinger C, Ress C, Laimer M, Engl J, et al. Long-term effects of weight loss after bariatric surgery on functional and structural markers of atherosclerosis. Obesity (Silver Spring). 2013;21(10):1960–5. doi: 10.1002/oby.20357 23512491

31. Hagman DK, Larson I, Kuzma JN, Cromer G, Makar K, Rubinow KB, et al. The short-term and long-term effects of bariatric/metabolic surgery on subcutaneous adipose tissue inflammation in humans. Metabolism. 2017;70:12–22. doi: 10.1016/j.metabol.2017.01.030 28403936

32. Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2003;42(5):878–84. doi: 10.1161/01.HYP.0000094221.86888.AE 12975389

33. Moore LL, Visioni AJ, Qureshi MM, Bradlee ML, Ellison RC, D'Agostino R. Weight loss in overweight adults and the long-term risk of hypertension: the Framingham study. Arch Intern Med. 2005;165(11):1298–303. doi: 10.1001/archinte.165.11.1298 15956011

34. Salminen P, Helmio M, Ovaska J, Juuti A, Leivonen M, Peromaa-Haavisto P, et al. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial. JAMA. 2018;319(3):241–54. doi: 10.1001/jama.2017.20313 29340676

35. Gibbons CJ, Fournier JC, Stirman SW, DeRubeis RJ, Crits-Christoph P, Beck AT. The clinical effectiveness of cognitive therapy for depression in an outpatient clinic. J Affect Disord. 2010;125(1–3):169–76. doi: 10.1016/j.jad.2009.12.030 20080305

36. Stenberg E, Szabo E, Ottosson J, Naslund I. Outcomes of laparoscopic gastric bypass in a randomized clinical trial compared with a concurrent national database. Br J Surg. 2017;104(5):562–9. doi: 10.1002/bjs.10448 28239833

37. Jans A, Naslund I, Ottosson J, Szabo E, Naslund E, Stenberg E. Duration of type 2 diabetes and remission rates after bariatric surgery in Sweden 2007–2015: A registry-based cohort study. PLoS Med. 2019;16(11):e1002985. doi: 10.1371/journal.pmed.1002985 31747392

38. Segal-Lieberman G, Segal P, Dicker D. Revisiting the Role of BMI in the Guidelines for Bariatric Surgery. Diabetes Care. 2016;39 Suppl 2:S268–73. doi: 10.2337/dcS15-3018 27440842

39. Global BMI Mortality Collaboration, Di Angelantonio E, Bhupathiraju Sh N, Wormser D, Gao P, Kaptoge S, et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet. 2016;388(10046):776–86. doi: 10.1016/S0140-6736(16)30175-1 27423262

40. Morgan TO, Nowson C, Murphy J, Snowden R. Compliance and the elderly hypertensive. Drugs. 1986;31 Suppl 4:174–83. doi: 10.2165/00003495-198600314-00021 2874009

Článek vyšel v časopise

PLOS Medicine

2020 Číslo 9
Nejčtenější tento týden
Nejčtenější v tomto čísle
Zapomenuté heslo

Nemáte účet?  Registrujte se

Zapomenuté heslo

Zadejte e-mailovou adresu, se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.


Nemáte účet?  Registrujte se